Compensation and Benefit Plans (Tables)

3 Months Ended

Mar. 31, 2023

Compensation And Retirement Disclosure [Abstract]

Summary of ESOP Shares

A summary of the ESOP shares as of March 31, 2023 and December 31, 2022 are as follows:

	March 31, 2023		December 31, 2022
	(Dollars in thousands)
Shares committed-to-be released		167,180		133,744
Shares allocated to participants		358,630		354,227
Unallocated shares		1,536,040		1,569,475
Total		2,061,850		2,057,446
Fair value of unallocated shares	$	12,058	$	14,628

Schedule of Restricted Stock Units Awards Activity and Related Information

A summary of the Company’s restricted stock unit awards activity and related information for three months ended March 31, 2023 and year ended December 31, 2022 are as follows:

	March 31, 2023
	Number of Shares			Weighted- Average Grant Date Fair Value Per Share
Non-vested, beginning of year		245,840		$	9.40
Granted		—			—
Vested		(4,147	)		9.27
Forfeited		—			—
Non-vested at March 31		241,693		$	9.40
	December 31, 2022
	Number of Shares			Weighted- Average Grant Date Fair Value Per Share
Non-vested, beginning of year		237,687		$	12.65
Conversion and reorganization		93,933			—
Granted		63,715			10.44
Vested		(149,495	)		9.11
Forfeited		—			—
Non-vested at December 31		245,840		$	9.40

Schedule of Stock Option Awards Activity and Related Information

A summary of the Company’s stock option awards activity and related information for three months ended March 31, 2023 and year ended December 31, 2022 are as follows:

	March 31, 2023
	Options		Weighted- Average Exercise Price Per Share
Outstanding, beginning of year		352,621	$	8.97
Granted		—		—
Exercised		—		—
Forfeited		—		—
Outstanding at March 31 (1)		352,621		8.97
Exercisable at March 31 (1)		191,752	$	8.83

	December 31, 2022
	Options		Weighted- Average Exercise Price Per Share
Outstanding, beginning of year		203,766	$	12.02
Conversion and reorganization		80,526	$	—
Granted		68,329		10.44
Exercised		—		—
Forfeited		—		—
Outstanding at December 31 (1)		352,621	$	8.97
Exercisable at December 31 (1)		190,508	$	8.83

(1)The aggregate intrinsic value, which represents the difference between the price of the Company’s common stock at respective periods and the stated exercise price of the underlying options, was $0 for outstanding options and $0 for exercisable options at March 31, 2023 and was $0.1 million for outstanding options and $0.1 million for exercisable options December 31, 2022.